Related Experiment Video

Updated: Feb 15, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

4.0K

Therapeutic potential of spinal GLP-1 receptor signaling

Dongao Zhang1, Gang Lv1

  • 1Department of Orthopaedics, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.

Peptides
|January 14, 2018
PubMed

Insights

Glucagon-like peptide-1 (GLP-1) receptor activation shows therapeutic potential for spinal cord injury. This pathway offers neuroprotection and may improve motor and sensory function after damage.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Regenerative Medicine

Background:

  • The glucagon-like peptide-1 (GLP-1) signaling pathway is crucial for glucose homeostasis and metabolism.
  • GLP-1 receptor (GLP-1R) activation demonstrates pro-survival and neuroprotective effects in various disorders, including neurodegenerative diseases.
  • GLP-1R is expressed in multiple organs, including the central nervous system and spinal cord.

Purpose of the Study:

  • To review existing research on the role of GLP-1 in the spinal cord.
  • To summarize GLP-1R expression and preproglucagon (PPG) neuron innervation within the spinal cord.
  • To explore the therapeutic potential of GLP-1R activation for spinal cord conditions.

Main Methods:

  • Literature review of studies investigating GLP-1 and the spinal cord.
  • Analysis of research on GLP-1R expression and PPG neuron distribution in the spinal cord.
  • Synthesis of evidence regarding the effects of GLP-1R activation on spinal cord function.

Main Results:

  • GLP-1R is expressed in the spinal cord, and PPG neurons innervate this region.
  • GLP-1 signaling exhibits beneficial effects and neuroprotective properties within the spinal cord.
  • GLP-1 analogs can cross the blood-brain barrier, potentially enhancing therapeutic efficacy.

Conclusions:

  • GLP-1R activation in the spinal cord holds significant therapeutic potential for conditions involving neural damage.
  • Further research into GLP-1 signaling may lead to novel treatments for spinal cord injuries and neurodegenerative disorders affecting the spinal cord.
Keywords:
Glucagon-like peptide-1Glucagon-like peptide-1 receptorSpinal cord

More Related Videos

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery05:13

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

527
Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo09:48

Measuring Spinal Presynaptic Inhibition in Mice By Dorsal Root Potential Recording In Vivo

Published on: March 29, 2014

14.5K

Related Concept Videos

Signal Sequences and Sorting Receptors01:41

Signal Sequences and Sorting Receptors

Signal sequences are short amino acid sequences that guide newly synthesized proteins to their proper location within the cell. Classical signal sequences are fifteen to sixty amino acids long and present at the N-terminus of a polypeptide chain. Each signal sequence has a conserved segment of basic residues towards their N terminus, a hydrophobic core, and a C-terminus rich in polar residues. The C-terminus also contains a signal cleavage site and features a -3 -1 sequence motif. The -3-1...
15.5K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.5K
Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule01:10

Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule

In the AX proton spin system, proton A can sense the two spin states of a coupled proton X, resulting in a doublet NMR signal with two peaks of equal (1:1) intensity. When proton A is coupled to two equivalent protons (AX2 spin system), the spin states of each X can be aligned with or against the external field, creating three possible scenarios. This results in a 1:2:1  triplet signal, where the central peak corresponds to the chemical shift of A and is twice as large or intense as the...
2.7K
Synaptic Signaling01:12

Synaptic Signaling

Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
79.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
652
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
17.4K